Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionCIBC Private Wealth Group, LLC
Latest Disclosed Ownership59,110 shares
Latest Disclosed Value $ 7,255,132
CIBC Private Wealth Group, LLC reports 1.99% decrease in ownership of GILD / Gilead Sciences, Inc.

On February 12, 2026 - CIBC Private Wealth Group, LLC filed a 13F-HR form disclosing ownership of 59,110 shares of Gilead Sciences, Inc. (US:GILD) valued at $7,255,161 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 24, 2025 disclosing 60,311 shares of Gilead Sciences, Inc.. This represents a change in shares of -1.99% during the quarter. The current value of the position is $7,624,599 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-12 2025-12-31 13F GILEAD SCIENCES COM 375558103 59,110 -1,201 -1.99 7,255 8.38 0.0123
2025-11-24 2025-09-30 13F GILEAD SCIENCES COM 375558103 60,311 -6,926 -10.30 6,694 -10.20 0.0115
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 67,237 21,768 47.87 7,455 58.90 0.0133
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 45,469 264 0.58 4,692 16.43 0.0099
2025-02-12 2024-12-31 13F Gilead Sciences COM 375558103 45,205 2,983 7.07 4,030 13.85 0.0073
2024-11-13 2024-09-30 13F Gilead Sciences COM 375558103 42,222 -2,008 -4.54 3,540 18.48 0.0063
2024-08-09 2024-06-30 13F Gilead Sciences COM 375558103 44,230 -1,030 -2.28 2,988 -9.43 0.0056
2024-05-10 2024-03-31 13F Gilead Sciences COM 375558103 45,260 -10,698 -19.12 3,299 -27.24 0.0065
2024-02-13 2023-12-31 13F GILEAD SCIENCES INC COM COM 375558103 55,958 -1,472 -2.56 4,533 5.35 0.0096
2023-11-13 2023-09-30 13F GILEAD SCIENCES INC COM COM 375558103 57,430 -8,891 -13.41 4,304 -15.81 0.0102
2023-11-21 2023-06-30 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 66,321 -4,540 -6.41 5,111 -30.04 0.0112
2023-08-10 2023-06-30 13F GILEAD SCIENCES INC COM COM 375558103 66,173 -4,688 5,100 0.0112
2023-11-21 2023-03-31 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 70,861 -4,005 -5.35 7,307 62.43 0.0162
2023-05-12 2023-03-31 13F GILEAD SCIENCES INC COM COM 375558103 70,713 -4,153 7,290 0.0158
2023-06-01 2022-12-31 13F/A-2 GILEAD SCIENCES INC COM COM 375558103 74,866 4,753 6.78 4,499 3.98 0.0151
2023-02-14 2022-12-31 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 74,948 4,835 6,434 0.0135
2023-02-13 2022-12-31 13F GILEAD SCIENCES INC COM COM 375558103 149,814 79,701 12,862 0.0000
2022-11-15 2022-09-30 13F GILEAD SCIENCES INC COM COM 375558103 70,113 963 1.39 4,326 1.22 0.0117
2022-08-03 2022-06-30 13F GILEAD SCIENCES COM 375558103 69,150 3,063 4.63 4,274 8.78 0.0111
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 66,087 -1,950 -2.87 3,929 -20.50 0.0086
2022-04-04 2021-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 68,037 -447 -0.65 4,942 3.30 0.0102
2022-02-08 2021-12-31 13F GILEAD SCIENCES COM 375558103 68,037 -447 4,942 0.0102
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 68,484 -425 -0.62 4,784 0.82 0.0111
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 68,909 508 0.74 4,745 7.35 0.0109
2021-05-12 2021-03-31 13F GILEAD SCIENCES COM 375558103 68,401 -6,679 -8.90 4,420 1.03 0.0111
2021-02-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 75,080 -196,114 -72.32 4,375 -74.47 0.0116
2020-11-03 2020-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 271,194 34,105 14.38 17,137 -6.05 0.0525
2020-08-13 2020-06-30 13F GILEAD SCIENCES INC COM Com 375558103 237,089 -14,724 -5.85 18,241 -3.11 0.0886
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 251,813 8,042 3.30 18,826 18.84 0.0807
2020-01-30 2019-12-31 13F GILEAD SCIENCES COM 375558103 243,771 -22,207 -8.35 15,842 -6.02 0.0517
2019-10-16 2019-09-30 13F GILEAD SCIENCES COM 375558103 265,978 15,643 6.25 16,857 -0.33 0.0593
2019-07-31 2019-06-30 13F GILEAD SCIENCES COM 375558103 250,335 19,165 8.29 16,913 12.54 0.0593
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 231,170 -9,894 -4.10 15,029 -0.33 0.0580
2019-02-05 2018-12-31 13F GILEAD SCIENCES COM 375558103 241,064 24,827 11.48 15,079 -9.69 0.0672
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 216,237 11,822 5.78 16,697 15.31 0.0633
2018-08-02 2018-06-30 13F GILEAD SCIENCES COM 375558103 204,415 18,894 10.18 14,480 3.52 0.0590
2018-05-17 2018-03-31 13F GILEAD SCIENCES COM 375558103 185,521 15,939 9.40 13,988 15.13 0.0608
2018-02-12 2017-12-31 13F GILEAD SCIENCES COM 375558103 169,582 20,797 13.98 12,150 0.78 0.0515
2017-12-21 2017-09-30 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 148,785 70,236 89.42 12,056 116.83 0.0550
2017-11-14 2017-09-30 13F GILEAD SCIENCES INC COM COM 375558103 148,785 70,236 12,056
2017-08-09 2017-06-30 13F GILEAD SCIENCES INC COM Com 375558103 78,549 21,372 37.38 5,560 43.19 0.0349
2017-05-10 2017-03-31 13F GILEAD SCIENCES INC COM Com 375558103 57,177 -7,849 -12.07 3,883 -16.62 0.0244
2017-02-13 2016-12-31 13F GILEAD SCIENCES INC COM Com 375558103 65,026 -118,627 -64.59 4,657 -67.95 0.0308
2016-11-09 2016-09-30 13F GILEAD SCIENCES INC COM Com 375558103 183,653 -40,588 -18.10 14,531 -22.32 0.1008
2016-08-11 2016-06-30 13F GILEAD SCIENCES INC COM Com 375558103 224,241 691 0.31 18,706 -8.91 0.1366
2016-05-11 2016-03-31 13F GILEAD SCIENCES INC COM Com 375558103 223,550 41,023 22.48 20,536 11.19 0.1587
2016-02-10 2015-12-31 13F GILEAD SCIENCES INC COM Com 375558103 182,527 52,554 40.43 18,470 44.73 0.1445
2015-11-12 2015-09-30 13F GILEAD SCIENCES INC COM Com 375558103 129,973 49,468 61.45 12,762 35.41 0.1050
2015-08-13 2015-06-30 13F GILEAD SCIENCES INC COM Com 375558103 80,505 17,973 28.74 9,425 53.60 0.0686
2015-05-11 2015-03-31 13F GILEAD SCIENCES INC COM Com 375558103 62,532 1,252 2.04 6,136 6.23 0.0453
2015-02-12 2014-12-31 13F GILEAD SCIENCES INC COM Com 375558103 61,280 -330 -0.54 5,776 -11.94 0.0442
2014-11-12 2014-09-30 13F GILEAD SCIENCES INC COM Com 375558103 61,610 -2,195 -3.44 6,559 23.99 0.0516
2014-08-13 2014-06-30 13F GILEAD SCIENCES INC COM Com 375558103 63,805 4,015 6.72 5,290 19.63 0.0429
2014-05-14 2014-03-31 13F GILEAD SCIENCES INC COM COM 375558103 59,790 59,790 4,422 0.0376
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.